SE7908995L - Heterocykliska foreningar - Google Patents

Heterocykliska foreningar

Info

Publication number
SE7908995L
SE7908995L SE7908995A SE7908995A SE7908995L SE 7908995 L SE7908995 L SE 7908995L SE 7908995 A SE7908995 A SE 7908995A SE 7908995 A SE7908995 A SE 7908995A SE 7908995 L SE7908995 L SE 7908995L
Authority
SE
Sweden
Prior art keywords
alkyl
different
same
phenyl
group
Prior art date
Application number
SE7908995A
Other languages
English (en)
Other versions
SE451071B (sv
Inventor
D Cox
H Cairns
N Chadwick
J L Suschitzky
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of SE7908995L publication Critical patent/SE7908995L/sv
Publication of SE451071B publication Critical patent/SE451071B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7908995A 1978-10-31 1979-10-30 Kveveheterocykliska foreningar innehallande pyrano- eller tiopyranoring, kompositioner innehallande dessa och forfarande for framstellning av dessa SE451071B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7842679 1978-10-31
GB7920760 1979-06-14

Publications (2)

Publication Number Publication Date
SE7908995L true SE7908995L (sv) 1980-05-01
SE451071B SE451071B (sv) 1987-08-31

Family

ID=26269406

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7908995A SE451071B (sv) 1978-10-31 1979-10-30 Kveveheterocykliska foreningar innehallande pyrano- eller tiopyranoring, kompositioner innehallande dessa och forfarande for framstellning av dessa

Country Status (32)

Country Link
US (1) US4419352A (sv)
AR (1) AR230449A1 (sv)
AT (1) AT379811B (sv)
AU (1) AU528648B2 (sv)
BR (1) BR7907006A (sv)
CA (1) CA1142520A (sv)
CH (1) CH643264A5 (sv)
CS (1) CS231166B2 (sv)
CU (1) CU21123A (sv)
DD (1) DD146954A5 (sv)
DE (1) DE2943658A1 (sv)
DK (1) DK458679A (sv)
FI (2) FI67702C (sv)
FR (1) FR2440371A1 (sv)
GR (1) GR73861B (sv)
HK (1) HK66185A (sv)
HU (1) HU183087B (sv)
IE (1) IE49464B1 (sv)
IL (1) IL58579A (sv)
KE (1) KE3540A (sv)
LU (1) LU81841A1 (sv)
MA (1) MA18631A1 (sv)
MY (1) MY8500439A (sv)
NL (1) NL7907916A (sv)
NO (1) NO154522C (sv)
NZ (1) NZ191956A (sv)
PH (1) PH15442A (sv)
PL (1) PL130691B1 (sv)
PT (1) PT70392A (sv)
SE (1) SE451071B (sv)
SG (1) SG40885G (sv)
SU (1) SU1014476A3 (sv)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260306A (en) * 1981-07-24 1993-11-09 Fisons Plc Inhalation pharmaceuticals
GB8402047D0 (en) * 1984-01-26 1984-02-29 Fisons Plc Nitrogen heterocycles
EP0162556B1 (en) * 1984-04-13 1991-11-06 FISONS plc Novels forms and formulations of nedocromil sodium
GB8501015D0 (en) * 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
GB8607159D0 (en) * 1986-03-22 1986-04-30 Smith & Nephew Ass Pharmaceutical composition
NL8701335A (nl) * 1986-06-21 1988-01-18 Sandoz Ag Orale farmaceutische preparaten.
USRE38628E1 (en) * 1986-12-23 2004-10-19 Fisons Plc Pharmaceutical compositions
EP0279121B1 (en) * 1986-12-23 1993-09-01 FISONS plc Pharmaceutical compositions comprising an aqueous solution of a pyranoquinoline derivative
USH672H (en) 1986-12-31 1989-09-05 E. R. Squibb & Sons, Inc. Stable antifungal capsule formulation
US4767612A (en) * 1987-01-23 1988-08-30 Rorer Pharmaceutical Corporation Triamcinolone acetonide for the treatment of allergic rhinitis
GB8704089D0 (en) * 1987-02-21 1987-03-25 Fisons Plc Method of treatment
EP0294914A3 (en) * 1987-03-17 1990-10-10 FISONS plc Nedocromil for the treatment of dermatological disorders
US5648084A (en) * 1990-02-28 1997-07-15 Guttag; Alvin Multiple dosage medicine drop bottle
CA2087423A1 (en) * 1990-07-25 1992-01-26 Tatsuki Shiota Benzopyran derivative, process for producing the same and pharmaceutical composition containing the same
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
US5453431A (en) * 1993-10-29 1995-09-26 Gilman; Andrew L. Use of hydroxychloroquine for treatment of graft-versus-host disease
ZA966579B (en) * 1995-08-04 1998-02-02 Wakamoto Pharma Co Ltd O/W emulsion composition for eye drops.
US5891472A (en) * 1996-11-19 1999-04-06 Meri Charmyne Russell Treatment of equine laminitis
US5989571A (en) * 1997-07-23 1999-11-23 Millenium Pharmaceutical Technologies, Inc. Contact dermatitis pharmaceutical preparation with anti-histamine and anti-inflammatory
US5885550A (en) * 1998-07-02 1999-03-23 Vallier; Deandra K. Ophthalmic whitening solution
US7101547B1 (en) 1999-01-22 2006-09-05 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance P by using anti-substance P antibodies
AU2001264616A1 (en) * 2000-05-17 2001-11-26 Cor Therapeutics, Inc. Methods for producing amino substituted chromanes and intermediates therefor
US9132116B2 (en) 2004-08-02 2015-09-15 Willowcroft Pharm Inc. Mast cell stabilizers to prevent or treat laminitis
GB0524808D0 (en) * 2005-12-05 2006-01-11 Novartis Ag Organic compounds
DE102007028095A1 (de) * 2007-06-19 2009-01-15 Bachmann, Vincent Zubereitung zur Behandlung von Hufrehe bei Equiden
FR2924344B1 (fr) * 2007-12-04 2010-04-16 Pf Medicament Utilisation de la mequitazine sous la forme de racemate ou d'enantiomeres pour la preparation d'un medicament destine au traitement ou a la prevention de pathologies impliquant les recepteurs histaminiques h4.
EP2424527B8 (en) * 2009-04-29 2019-07-17 Willowcraft Pharm Inc. Mast cell stabilizers to prevent or treat laminitis
CN116660407A (zh) * 2023-05-18 2023-08-29 北京镁伽机器人科技有限公司 2,2-联喹啉-4,4-二甲酸二钠在腺病毒相关病毒滴度检测中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1504709A (en) * 1974-12-07 1978-03-22 Fisons Ltd N-substituted quinolinone-2-carboxyl. acid der
AU513456B2 (en) * 1977-03-08 1980-12-04 Takeda Chemical Industries Ltd. l-Azaxanthone-3-carboxylic acids
IL54614A (en) * 1977-05-04 1983-07-31 Fisons Ltd Dihydrodioxo-pyranoquinoline dicarboxylic acid derivatives,their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
FI67702C (fi) 1985-05-10
CH643264A5 (fr) 1984-05-30
US4419352A (en) 1983-12-06
IL58579A0 (en) 1980-01-31
IL58579A (en) 1985-12-31
CS231166B2 (en) 1984-10-15
DK458679A (da) 1980-05-01
FR2440371A1 (fr) 1980-05-30
DE2943658A1 (de) 1980-05-14
AR230449A1 (es) 1984-04-30
GR73861B (sv) 1984-05-08
HU183087B (en) 1984-04-28
AU5228779A (en) 1980-05-08
MA18631A1 (fr) 1980-07-01
MY8500439A (en) 1985-12-31
FI813127L (fi) 1981-10-08
AU528648B2 (en) 1983-05-05
PL219304A1 (sv) 1980-12-01
LU81841A1 (fr) 1980-05-07
DD146954A5 (de) 1981-03-11
AT379811B (de) 1986-03-10
BR7907006A (pt) 1980-07-15
FI813127A7 (sv) 1981-10-08
NO154522C (no) 1986-10-08
NZ191956A (en) 1984-05-31
FR2440371B1 (sv) 1983-01-28
CA1142520A (en) 1983-03-08
PH15442A (en) 1983-01-18
PL130691B1 (en) 1984-08-31
SU1014476A3 (ru) 1983-04-23
IE792074L (en) 1980-04-30
SG40885G (en) 1986-05-02
HK66185A (en) 1985-09-13
NO793469L (no) 1980-05-02
FI793369A7 (fi) 1980-05-01
ATA701479A (de) 1985-07-15
IE49464B1 (en) 1985-10-16
FI67702B (fi) 1985-01-31
PT70392A (en) 1979-11-01
DE2943658C2 (sv) 1991-08-01
NL7907916A (nl) 1980-05-02
SE451071B (sv) 1987-08-31
CS735979A2 (en) 1984-02-13
CU21123A (es) 1982-08-28
KE3540A (en) 1985-07-12
NO154522B (no) 1986-06-30

Similar Documents

Publication Publication Date Title
IE792074L (en) Pyran- and thiopyran-fused heterocyclic compounds
SE7903698L (sv) Heterocykliska foreningar
SE7712455L (sv) Farmaceutiskt aktiva foreningar
SE7905402L (sv) Fenyl-piperazinderivat
DE69003200D1 (de) Arylsubstituierte Aminderivate verwendbar in der Krebstherapie.
ATE10804T1 (de) Ein diphenylhydantoin-derivat enthaltende pharmazeutische zusammensetzung, verwendete derivate und ihre herstellung.
ATE74352T1 (de) Dekahydrochinolinderivate, verfahren zu ihrer herstellung, zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
SE7606440L (sv) Nya n-substituerade bensensulfonamider och sett att framstella desamma
ES8306753A1 (es) "procedimiento para la preparacion de nuevos derivados de azepina".
SE7501365L (sv)
ES2012648A6 (es) Procedimiento para la preparacion de nuevos derivados de 1,4-benzoxazina y 1,4-benzotiazina.
HUP9700955A2 (hu) Szubsztituált 2-naftoil-guanidin-származékok, előállításuk, valamint az e vegyületeket tartalmazó gyógyszerkészítmények
ES508343A0 (es) "procedimiento para la preparacion de nuevas pirimido (5,4-d) pirimidinas trisustituidas".
SE7706346L (sv) Bensaminderivat
ATE3294T1 (de) 6-aminosubstituierte n-pyrrolyl-3-pyridazinamine, deren herstellung und sie enthaltende pharmazeutische antihypertensive zusammensetzungen.
ES467069A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1-3-bencenodimetanol
ES2057802T3 (es) Nuevos derivados de 3-amino-cromano, procedimiento de preparacion y composiciones farmaceuticas que los contienen.
SE7704536L (sv) Forfarande for framstellning av fenylpiperazinderivat
SE8303913D0 (sv) Heterocykliska foreningar
ES500810A0 (es) Procedimiento de preparacion de aminoalcoxipirazoles
JO1047B1 (en) Vehicles
SE7605899L (sv) Forfarande for framstellning av tienopyridinderivat
ES443093A1 (es) Un procedimiento para la produccion de derivados de benzopi-rano.
ES8203360A1 (es) Un procedimiento para la preparacion de nuevos derivados de aminoalquilbenzofurano.
ATE772T1 (de) Thiazolderivate, ihre herstellung und sie enthaltende arzneimittel.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7908995-9

Effective date: 19940510

Format of ref document f/p: F